<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US5739114 - Immunosuppressive cyclolignan derivatives - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Immunosuppressive cyclolignan derivatives"><meta name="DC.contributor" content="Marina Gordaliza" scheme="inventor"><meta name="DC.contributor" content="Maria Angeles Castro" scheme="inventor"><meta name="DC.contributor" content="Arturo San Feliciano" scheme="inventor"><meta name="DC.contributor" content="Jose Maria Miguel del Corral" scheme="inventor"><meta name="DC.contributor" content="Maria Luisa Lopez" scheme="inventor"><meta name="DC.contributor" content="Glynn T. Faircloth" scheme="inventor"><meta name="DC.contributor" content="Universidad De Salamanca" scheme="assignee"><meta name="DC.date" content="1995-11-13" scheme="dateSubmitted"><meta name="DC.description" content="Immunosuppressive cyclolignan derivatives are provided of formula (I) or (II): ##STR1## in which R1 is hydrogen, hydroxy, alkoxy; R2 and R3 are hydrogen, alkyl, acyl, or together R2 and R3 form a group --CHR4 --; R4 is hydrogen, alkyl, alkenyl, hydroxyalkyl, (poly)haloalkyl, aryl, acyloxyalkyl, alkoxy, carboxyalkyl, alkoxycarbonyl, carbamoyl; R5 when present is hydrogen, alkyl, alkenyl, aryl, (poly)haloalkyl, acyl, carbamoyl, or thiocarbamoyl; R6 is alkyl, hydroxyalkyl, haloalkyl, acyl, acyloxyalkyl, carboxy or alkoxycarbonyl; Ar is 3,4,5-trialkoxyphenyl or 4-hydroxy-3,5-dialkoxyphenyl; and X is nitrogen or oxygen."><meta name="DC.date" content="1998-4-14" scheme="issued"><meta name="DC.relation" content="DE:3612278:A1" scheme="references"><meta name="DC.relation" content="US:4567253" scheme="references"><meta name="DC.relation" content="US:4644072" scheme="references"><meta name="DC.relation" content="WO:1986004062:A1" scheme="references"><meta name="citation_reference" content="Buchardt et al., &quot;Thermal Chemistry of Podophyllotoxin in Ethanol and a Comparison of the Cytostatic Activity of the Thermolysis Products&quot;, Journal of Pharmaceutical Sciences, vol. 75, No. 11, Nov. 1986, pp. 1076-1080."><meta name="citation_reference" content="Buchardt et al., Thermal Chemistry of Podophyllotoxin in Ethanol and a Comparison of the Cytostatic Activity of the Thermolysis Products , Journal of Pharmaceutical Sciences, vol. 75, No. 11, Nov. 1986, pp. 1076 1080."><meta name="citation_reference" content="Forsey et al., &quot;Comprehensive Synthetic Route to Eight Diastereomeric Podophyllum Lignans&quot;, The Journal of Organic Chemistry, vol. 54, No. 18, 1 Sep. 1989, pp. 4280-4290."><meta name="citation_reference" content="Forsey et al., Comprehensive Synthetic Route to Eight Diastereomeric Podophyllum Lignans , The Journal of Organic Chemistry, vol. 54, No. 18, 1 Sep. 1989, pp. 4280 4290."><meta name="citation_reference" content="Gordaliza et al., &quot;Antineoplastic and antiviral activities of podophyllotoxin related lignans&quot;, Chemical Abstracts, vol. 120, No. 19, Abstract No. 120: 235425c. (May 9, 1994)."><meta name="citation_reference" content="Gordaliza et al., &quot;Antineoplastic and Antiviral Activities of Podophyllotoxin Related Lignans,&quot;, Arch Pharm., vol. 327, No. 3, 1994, pp. 175-179."><meta name="citation_reference" content="Gordaliza et al., Antineoplastic and antiviral activities of podophyllotoxin related lignans , Chemical Abstracts, vol. 120, No. 19, Abstract No. 120: 235425c. (May 9, 1994)."><meta name="citation_reference" content="Gordaliza et al., Antineoplastic and Antiviral Activities of Podophyllotoxin Related Lignans, , Arch Pharm., vol. 327, No. 3, 1994, pp. 175 179."><meta name="citation_reference" content="Hansen et al., &quot;New Compounds Related to Podophyllotoxin and Congeners: Synthesis, Structure Elucidation and Biological Testing&quot;. Acta Chemica Scandinavica, vol. 47 (1993), pp. 1190-1200."><meta name="citation_reference" content="Hansen et al., New Compounds Related to Podophyllotoxin and Congeners: Synthesis, Structure Elucidation and Biological Testing . Acta Chemica Scandinavica, vol. 47 (1993), pp. 1190 1200."><meta name="citation_reference" content="Hartwell and Schrecker, &quot;The Chemistry of Podophyllum&quot;, Progress in the Chemistry of Organic Natural Products, pp. 84-166, 1957."><meta name="citation_reference" content="Hartwell and Schrecker, The Chemistry of Podophyllum , Progress in the Chemistry of Organic Natural Products, pp. 84 166, 1957."><meta name="citation_reference" content="Jones et al., &quot;Synthesis of (±)-4-Deoxypodophyllotoxin, (±)-Podophyllotoxin and (±)-Epipodophyllotoxin&quot;, Journal of the Chemical Society, Perkin Transactions 1, Nov., 1993, pp. 2541-2548."><meta name="citation_reference" content="Jones et al., Synthesis of ( ) 4 Deoxypodophyllotoxin, ( ) Podophyllotoxin and ( ) Epipodophyllotoxin , Journal of the Chemical Society, Perkin Transactions 1, Nov., 1993, pp. 2541 2548."><meta name="citation_reference" content="Terada et al., &quot;Antitumor Agents. I. DNA Topoisomerase II Inhibitory Activity and the Structural Relationship of Podophyllotoxin Derivatives as Antitumor Agents&quot;, Chem. Pharm. Bull., 40(10) 2720-2727, 1992."><meta name="citation_reference" content="Terada et al., &quot;Antitumor Agents. I. DNA Topoisomerase II Inhibitory Activity and the Structure Relationship of Podophyllotoxin Derivatives as Antitumor Agents&quot;, Chemical &amp; Pharmaceutical Bulletin, vol. 40, No. 10, Oct. 1992, pp. 2720-2727."><meta name="citation_reference" content="Terada et al., Antitumor Agents. I. DNA Topoisomerase II Inhibitory Activity and the Structural Relationship of Podophyllotoxin Derivatives as Antitumor Agents , Chem. Pharm. Bull., 40(10) 2720 2727, 1992."><meta name="citation_reference" content="Terada et al., Antitumor Agents. I. DNA Topoisomerase II Inhibitory Activity and the Structure Relationship of Podophyllotoxin Derivatives as Antitumor Agents , Chemical &amp; Pharmaceutical Bulletin, vol. 40, No. 10, Oct. 1992, pp. 2720 2727."><meta name="citation_reference" content="Thurston et al., &quot;Antitumor Agents. 100. Inhibition of Human DNA Topoisomerase II by Cytotoxic Ether and Ester Derivatives of Podophyllotoxin and α-Peltatin&quot;, Journal of Medical Chemistry, vol. 32, No. 3, Mar. 1986, pp. 604-608."><meta name="citation_reference" content="Thurston et al., &quot;Antitumor Agents. 78. Inhibition of Human DNA Topoisomerase II by Podophyllotoxin and α-Peltatin Analogues&quot;, J. Med. Chem., 29:1547-1550, 1986."><meta name="citation_reference" content="Thurston et al., Antitumor Agents. 100. Inhibition of Human DNA Topoisomerase II by Cytotoxic Ether and Ester Derivatives of Podophyllotoxin and Peltatin , Journal of Medical Chemistry, vol. 32, No. 3, Mar. 1986, pp. 604 608."><meta name="citation_reference" content="Thurston et al., Antitumor Agents. 78. Inhibition of Human DNA Topoisomerase II by Podophyllotoxin and Peltatin Analogues , J. Med. Chem., 29:1547 1550, 1986."><meta name="citation_patent_number" content="US:5739114"><meta name="citation_patent_application_number" content="US:08/558,127"><link rel="canonical" href="http://www.google.com/patents/US5739114"/><meta property="og:url" content="http://www.google.com/patents/US5739114"/><meta name="title" content="Patent US5739114 - Immunosuppressive cyclolignan derivatives"/><meta name="description" content="Immunosuppressive cyclolignan derivatives are provided of formula (I) or (II): ##STR1## in which R1 is hydrogen, hydroxy, alkoxy; R2 and R3 are hydrogen, alkyl, acyl, or together R2 and R3 form a group --CHR4 --; R4 is hydrogen, alkyl, alkenyl, hydroxyalkyl, (poly)haloalkyl, aryl, acyloxyalkyl, alkoxy, carboxyalkyl, alkoxycarbonyl, carbamoyl; R5 when present is hydrogen, alkyl, alkenyl, aryl, (poly)haloalkyl, acyl, carbamoyl, or thiocarbamoyl; R6 is alkyl, hydroxyalkyl, haloalkyl, acyl, acyloxyalkyl, carboxy or alkoxycarbonyl; Ar is 3,4,5-trialkoxyphenyl or 4-hydroxy-3,5-dialkoxyphenyl; and X is nitrogen or oxygen."/><meta property="og:title" content="Patent US5739114 - Immunosuppressive cyclolignan derivatives"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("MSnuU8vFM7fcsATk2IHAAg"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("PRT"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("MSnuU8vFM7fcsATk2IHAAg"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("PRT"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us5739114?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US5739114"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=fs1FBAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS5739114&amp;usg=AFQjCNE475SfvU35QUoNO-x8Jd1uxjuCow" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US5739114.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US5739114.pdf"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US5739114" style="display:none"><span itemprop="description">Immunosuppressive cyclolignan derivatives are provided of formula (I) or (II): ##STR1## in which R1 is hydrogen, hydroxy, alkoxy; R2 and R3 are hydrogen, alkyl, acyl, or together R2 and R3 form a group --CHR4 --; R4 is hydrogen, alkyl, alkenyl, hydroxyalkyl, (poly)haloalkyl, aryl, acyloxyalkyl, alkoxy,...</span><span itemprop="url">http://www.google.com/patents/US5739114?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US5739114 - Immunosuppressive cyclolignan derivatives</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US5739114 - Immunosuppressive cyclolignan derivatives" title="Patent US5739114 - Immunosuppressive cyclolignan derivatives"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US5739114 A</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 08/558,127</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Apr 14, 1998</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Nov 13, 1995</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Nov 14, 1994</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Lapsed</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/CA2162760A1">CA2162760A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE69531586D1">DE69531586D1</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE69531586T2">DE69531586T2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0711765A1">EP0711765A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0711765B1">EP0711765B1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0711765B9">EP0711765B9</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">08558127, </span><span class="patent-bibdata-value">558127, </span><span class="patent-bibdata-value">US 5739114 A, </span><span class="patent-bibdata-value">US 5739114A, </span><span class="patent-bibdata-value">US-A-5739114, </span><span class="patent-bibdata-value">US5739114 A, </span><span class="patent-bibdata-value">US5739114A</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Marina+Gordaliza%22">Marina Gordaliza</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Maria+Angeles+Castro%22">Maria Angeles Castro</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Arturo+San+Feliciano%22">Arturo San Feliciano</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Jose+Maria+Miguel+del+Corral%22">Jose Maria Miguel del Corral</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Maria+Luisa+Lopez%22">Maria Luisa Lopez</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Glynn+T.+Faircloth%22">Glynn T. Faircloth</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Universidad+De+Salamanca%22">Universidad De Salamanca</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US5739114.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5739114.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5739114.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (4),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (22),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (27),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (10)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/5739114&usg=AFQjCNFRay-Na1xx4UYsq10JKnJJl7U2FA">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D5739114&usg=AFQjCNFs_NbSd07JFn5m3CbWTwzZYrFQWg">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D5739114A%26KC%3DA%26FT%3DD&usg=AFQjCNEOtVlJlyC6VSShZkcp2TITlT5Ahg">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT54274499" lang="EN" load-source="patent-office">Immunosuppressive cyclolignan derivatives</invention-title></span><br><span class="patent-number">US 5739114 A</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA131517149" lang="EN" load-source="patent-office"> <div class="abstract">Immunosuppressive cyclolignan derivatives are provided of formula (I) or (II): ##STR1## in which R<sup>1</sup> is hydrogen, hydroxy, alkoxy; R<sup>2</sup> and R<sup>3</sup> are hydrogen, alkyl, acyl, or together R<sup>2</sup> and R<sup>3</sup> form a group --CHR<sup>4</sup> --; R<sup>4</sup> is hydrogen, alkyl, alkenyl, hydroxyalkyl, (poly)haloalkyl, aryl, acyloxyalkyl, alkoxy, carboxyalkyl, alkoxycarbonyl, carbamoyl; R<sup>5</sup> when present is hydrogen, alkyl, alkenyl, aryl, (poly)haloalkyl, acyl, carbamoyl, or thiocarbamoyl; R<sup>6</sup> is alkyl, hydroxyalkyl, haloalkyl, acyl, acyloxyalkyl, carboxy or alkoxycarbonyl; Ar is 3,4,5-trialkoxyphenyl or 4-hydroxy-3,5-dialkoxyphenyl; and X is nitrogen or oxygen.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(6)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5739114-0.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5739114-0.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5739114-1.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5739114-1.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5739114-2.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5739114-2.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5739114-3.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5739114-3.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5739114-4.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5739114-4.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5739114-5.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5739114-5.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(5)</span></span></div><div class="patent-text"><div mxw-id="PCLM59467949" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>We claim:</claim-statement> <div class="claim"> <div num="1" class="claim">
      <div class="claim-text">1. A compound of the formula (I): ##STR5## wherein: R<sup>1</sup> is hydrogen or hydroxy;<div class="claim-text">R<sup>2</sup> and R<sup>3</sup> are hydrogen;<div class="claim-text">and</div> </div> <div class="claim-text">Ar is 3,4,5-trialkyoxyphenyl.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="2" class="claim">
      <div class="claim-text">2. The compound of claim 1, which is 3,4-O-demethylenedeoxy-picropodophyllin.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="3" class="claim">
      <div class="claim-text">3. The compound of claim 1, which is 3,4-O-demethylene-epipodophyllotoxin.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="4" class="claim">
      <div class="claim-text">4. The compound of claim 1, which is 3, 4-O-demethylene-podophyllotoxin.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="5" class="claim">
      <div class="claim-text">5. A pharmaceutical composition that comprises an effective immunosuppressive amount of a compound as defined any of claims 1-4 together with a pharmaceutically acceptable carrier.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES67100658" lang="EN" load-source="patent-office" class="description">
    <p>This invention is concerned with cyclolignan derivatives, the preparation of such derivatives, and pharmaceutical compositions containing them.</p>
    <p>It has now been found, in accordance with the present invention, that certain cyclolignan derivatives, as hereinafter defined, possess immunomodulatory activity, as evidenced by both the in vitro Mixed Lymphocyte Reaction (MLR) and the in vivo Graft-vs.-Host Reaction (GVHR) and Suppression Graft (SG) tests.</p>
    <p>Accordingly, the invention provides cyclolignan derivatives of the formulae (I) and (II): ##STR2## in which: R<sup>1</sup> is hydrogen, hydroxy, alkoxy;</p>
    <p>R<sup>2</sup> and R<sup>3</sup> are hydrogen, alkyl, acyl, or together R<sup>2</sup> and R<sup>3</sup> form a group --CHR<sup>4</sup> --;</p>
    <p>R<sup>4</sup> is hydrogen, alkyl, alkenyl, hydroxyalkyl, (poly)haloalkyl, aryl, acyloxyalkyl, alkoxy, carboxyalkyl, alkoxycarbonyl, carbamoyl;</p>
    <p>R<sup>5</sup> when present is hydrogen, alkyl, alkenyl, aryl, (poly)haloalkyl, acyl, carbamoyl, or thiocarbamoyl;</p>
    <p>R<sup>6</sup> is alkyl, hydroxyalkyl, haloalkyl, acyl, acyloxyalkyl, carboxy or alkoxycarbonyl;</p>
    <p>Ar is 3,4,5-trialkoxyphenyl or 4-hydroxy-3,5-dialkoxyphenyl; and</p>
    <p>X is nitrogen or oxygen.</p>
    <heading>PREFERRED EMBODIMENTS</heading> <p>The alkoxy groups preferably have from 1 to 6 carbon atoms, more preferably 1 to 4 carbon atoms. Examples include methoxy, ethoxy, propoxy, isopropoxy, butoxy, t-butoxy and other alkoxy groups.</p>
    <p>The alkyl groups preferably have from 1 to 6 carbon atoms, more preferably 1 to 4 carbon atoms. Examples include methyl, ethyl, propyl, isopropyl, butyl, t-butyl and other alkyl groups.</p>
    <p>The acyl groups preferably have from 1 to 20 carbon atoms, and more preferably are either short-chain acyl groups with 1 to 3 carbon atoms or long-chain acyl groups with 12 to 18 carbon atoms. The long chain acyl groups may be saturated or unsaturated, preferably of the kind occurring in natural fatty acids. Examples of acyl groups include formyl, acetyl or stearyl.</p>
    <p>The alkenyl groups preferably have from 2 to 6 carbon atoms, more preferably 2 to 4 carbon atoms. Examples include vinyl or butenyl groups.</p>
    <p>The hydroxyalkyl groups preferably have from 1 to 6 carbon atoms, more preferably 1 to 4 carbon atoms. Examples include hydroxymethyl, 1- or 2-hydroxyethyl or 3-hydroxypropyl and other hydroxyalkyl groups.</p>
    <p>The haloalkyl and polyhaloalkyl groups preferably have from 1 to 6 carbon atoms, more preferably 1 to 4 carbon atoms, and preferably have a fluoro, chloro or bromo group. The (poly)haloalkyl groups are suitably monohalo or perhalo groups. Examples include chloromethyl or perfluomethyl groups.</p>
    <p>The aryl group is preferably a phenyl or substituted phenyl group, suitably substituted with groups R<sup>4</sup> or R<sup>5</sup>.</p>
    <p>The preferred remaining possibilities for R<sup>4</sup>, R<sup>5</sup> and R<sup>6</sup> follow the same general principles.</p>
    <p>When R<sup>2</sup> and R<sup>3</sup> together form a group --CHR<sup>4</sup> --, it is preferred that R<sup>4</sup> is an alkoxycarbonyl group.</p>
    <p>The present compounds can exist as optical isomers, and the invention embraces the individual isomers and mixtures thereof, including the diastereomeric or racemic mix. The stereochemistry of the substituents may be selected as desired, and for example the groups R<sup>1</sup> and R<sup>6</sup> can be α or β.</p>
    <p>More generally, the preferred compounds of this invention include compounds of formula (I), wherein the methylene group of the dioxolo moiety of podophyllium lignans has been removed or changed and the compounds of formula (II) with a fused imidazo or isoxazo ring.</p>
    <p>Individual preferred compounds of this invention include</p>
    <p>AP-37, which is 3,4-O-demethylenedeoxypicropodophyllin;</p>
    <p>AP-39, which is 3,4-O-demethyleneepipodophyllotoxin;</p>
    <p>AP-40, which is 3,4-O-demethylenepodophyllotoxin;</p>
    <p>AP-47, which is 10-methoxycarbonyldeoxypicropodophyllin;</p>
    <p>LL-4, which is methyl phenylpyrazopodophyllate; and</p>
    <p>LL-11, which is isoxazopodophyllic acid.</p>
    <p>Compounds of formula (I), and (II), as noted above, have immunomodulatory activity and, accordingly, the invention provides immunosuppressive pharmaceutical compositions comprising compounds of formula (I) or (II) as defined above in association with a pharmaceutical carder. Such pharmaceutical compositions may, for example, be adapted for oral, parenteral, or rectal administration by the incorporation or appropriate pharmaceutical carriers and options adjuvants. The invention also provides the use of cyclolignan derivatives of formula (I) and (II) in the manufacture of immunosuppressive compositions.</p>
    <p>The immunosuppressive activity of various compounds in accordance with the invention is summarised below.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Immunosuppressive effectsof several representative cyclolignans               GVHRCompound    dose<sup>a</sup>               index<sup>b</sup>                         SG index<sup>c</sup>                                Cytotox.<sup>d</sup>______________________________________AP-37       0.1     58        --     &gt;20AP-39       1.5     --        200    &gt;10AP-40       1.5     --        229    0.5AP-47       10      56        --     2.5LL-4        1       53        --     1LL-11       0.15    --        204    &gt;10Cyclophosphamide       200     79        --     --Cyclosporin A       25      --        .sup. 178<sup>e</sup>                                --______________________________________ <sup>a</sup> mg/kg/day (7 days) <sup>b</sup> % reduction of spleen weight with respect to non treated animals. <sup>c</sup> % of implant duration with respect to non treated animals. <sup>d</sup> IC<sub>50</sub> (μg/ml) for monkey kidney fibroblasts. <sup>e</sup> 20% of the animals died in this experiment before the end of the program (30 days of observation).</pre>
    
    <p>The compounds in accordance with the invention may be prepared from podophyllotoxin and analogues formula: ##STR3##</p>
    <p>For example, see A.W. Fortschrite Chem. Org. Naturstoff 15.83 (1953) which describes podophyllotoxin where R is hydroxy and 8'--H is β; deoxypodophyllotoxin where R is hydrogen and 8'--H is β; and deoxypicropodophyllin where R is hydrogen and 8'--H is α. See also J. Med. Chem. 29 1547-1550 (1986) and Chem. Pharm. Bull. 40 2720-2727 (1992).</p>
    <p>For example, compounds of this invention can be made in accordance with the following reaction scheme, where partial structures are shown as appropriate: ##STR4## where reaction a) is esterification and/or reduction and/or acylation and/or oxidation in the adequate sequence and combination.</p>
    <p>Other equivalent reaction conditions can be employed.</p>
    <heading>EXAMPLES OF THE INVENTION</heading> <p>In order that the invention may be further understood, the following examples are given by way of illustration only.</p>
    <heading>EXAMPLE 1</heading> <p>Preparation of AP-37:</p>
    <p>To a solution of boron trichloride in CH<sub>2</sub> Cl<sub>2</sub> (1M, 2 ml) precooled at -70° to -65° was added dropwise deoxypicropodophyllin (100 mg) in dry CH<sub>2</sub> Cl<sub>2</sub> (6 ml). After stirring at the same temperature for an additional 1 hour, the mixture was poured into ice-water and extracted with ethyl acetate. The residue obtained after evaporating the organic solvent was dissolved in a mixture of water:acetone:calcium carbonate (3 ml:3 ml: 1 g) and refluxed for 1 hour. The suspension was acidified with 2N HCl and extracted with ethyl acetate. Evaporation of the solvent afforded 80 mg of AP-37.</p>
    <p> M+!:386 mp:226°-228° C. (MeOH)  α!<sub>D</sub> (CHCl<sub>3</sub>):+46.8° UV λ<sub>max</sub> (EtOH)(ε):222(23300), 288(7200) IR (KBr):3400,1740,1600,1510,1300,1110 cm<sup>-1</sup>.</p>
    <heading>EXAMPLE 2</heading> <p>Preparation of AP-47:</p>
    <p>A mixture of AP-37 (50 mg), methyl dichloroacetate (0.06 ml) and anhydrous K<sub>2</sub> CO<sub>3</sub> (100 mg) in DMF (2 ml) was stirred at 90°-100° C. under argon for 2 hours. After cooling the mixture, water (3 ml) was added and stirred again at 90°-100° C. for 40 min. then acidified with 2N HCl, basified with saturated NaHCO<sub>3</sub> and extracted with ethyl acetate. The aqueous layer was acidified with 2N HCl and extracted with EtOAc. Evaporation of the solvent afforded 40 mg of AP-47.</p>
    <p>mp: 95°-98° C. (MeOH/CH<sub>2</sub> Cl<sub>2</sub>)  α!<sub>D</sub> (CHCl<sub>3</sub>):+20.6° UV λ<sub>max</sub> (EtOH)(ε):214(20500), 290(3600) IR (CHCl<sub>3</sub>):3010,1770,1600,1500,1480,1220,1140 cm<sup>-1</sup>.</p>
    <heading>EXAMPLE 3</heading> <p>Preparation of LL-11</p>
    <p>0.2 ml of pyridine and 64 mg of hydroxylamine hydrochloride were added to a solution of 300 mg ofpodophyllotoxone in 15 ml of ethanol. The reaction mixture was stirred at 95° C. for 72 h. Then it was concentrated under vacuum and extracted with ethyl acetate. The reaction product was purified by flash chromatography to provide 250 mg of LL-11.</p>
    <p> M+!:428 mp:246°-248° C.(CH<sub>2</sub> Cl<sub>2</sub>)  α!<sub>D</sub> (CHCl<sub>3</sub>):-152.6° UV λ<sub>max</sub> (EtOH)(ε):215(26500),274(12000),313(8900). IR(KBr):3600,-2700,1700,1600,1510,1240,1130 cm<sup>-1</sup>.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4567253">US4567253</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 3, 1984</td><td class="patent-data-table-td patent-date-value">Jan 28, 1986</td><td class="patent-data-table-td ">Tony Durst</td><td class="patent-data-table-td ">2-Substituted derivatives of podophyllotoxin and etoposide</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4644072">US4644072</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 12, 1985</td><td class="patent-data-table-td patent-date-value">Feb 17, 1987</td><td class="patent-data-table-td ">Bristol-Myers Company</td><td class="patent-data-table-td ">Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/DE3612278A1?cl=en">DE3612278A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 11, 1986</td><td class="patent-data-table-td patent-date-value">Oct 16, 1986</td><td class="patent-data-table-td ">Bristol Myers Co</td><td class="patent-data-table-td ">Zwischenverbindungen fuer die herstellung von epipodophyllotoxin und verwandten verbindungen und verfahren zur herstellung dieser verbindungen</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1986004062A1?cl=en">WO1986004062A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 20, 1985</td><td class="patent-data-table-td patent-date-value">Jul 17, 1986</td><td class="patent-data-table-td ">Conpharm Ab</td><td class="patent-data-table-td ">Pharmaceutically active compound and a method for its preparation</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Buchardt et al., "<a href='http://scholar.google.com/scholar?q="Thermal+Chemistry+of+Podophyllotoxin+in+Ethanol+and+a+Comparison+of+the+Cytostatic+Activity+of+the+Thermolysis+Products"'>Thermal Chemistry of Podophyllotoxin in Ethanol and a Comparison of the Cytostatic Activity of the Thermolysis Products</a>", Journal of Pharmaceutical Sciences, vol. 75, No. 11, Nov. 1986, pp. 1076-1080.</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Buchardt et al., Thermal Chemistry of Podophyllotoxin in Ethanol and a Comparison of the Cytostatic Activity of the Thermolysis Products , Journal of Pharmaceutical Sciences, vol. 75, No. 11, Nov. 1986, pp. 1076 1080.</td></tr><tr><td class="patent-data-table-td ">3</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Forsey et al., "<a href='http://scholar.google.com/scholar?q="Comprehensive+Synthetic+Route+to+Eight+Diastereomeric+Podophyllum+Lignans"'>Comprehensive Synthetic Route to Eight Diastereomeric Podophyllum Lignans</a>", The Journal of Organic Chemistry, vol. 54, No. 18, 1 Sep. 1989, pp. 4280-4290.</td></tr><tr><td class="patent-data-table-td ">4</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Forsey et al., Comprehensive Synthetic Route to Eight Diastereomeric Podophyllum Lignans , The Journal of Organic Chemistry, vol. 54, No. 18, 1 Sep. 1989, pp. 4280 4290.</td></tr><tr><td class="patent-data-table-td ">5</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Gordaliza et al., "<a href='http://scholar.google.com/scholar?q="Antineoplastic+and+antiviral+activities+of+podophyllotoxin+related+lignans"'>Antineoplastic and antiviral activities of podophyllotoxin related lignans</a>", Chemical Abstracts, vol. 120, No. 19, Abstract No. 120: 235425c. (May 9, 1994).</td></tr><tr><td class="patent-data-table-td ">6</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Gordaliza et al., "<a href='http://scholar.google.com/scholar?q="Antineoplastic+and+Antiviral+Activities+of+Podophyllotoxin+Related+Lignans%2C"'>Antineoplastic and Antiviral Activities of Podophyllotoxin Related Lignans,</a>", Arch Pharm., vol. 327, No. 3, 1994, pp. 175-179.</td></tr><tr><td class="patent-data-table-td ">7</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Gordaliza et al., Antineoplastic and antiviral activities of podophyllotoxin related lignans , Chemical Abstracts, vol. 120, No. 19, Abstract No. 120: 235425c. (May 9, 1994).</td></tr><tr><td class="patent-data-table-td ">8</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Gordaliza et al., Antineoplastic and Antiviral Activities of Podophyllotoxin Related Lignans, , Arch Pharm., vol. 327, No. 3, 1994, pp. 175 179.</td></tr><tr><td class="patent-data-table-td ">9</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Hansen et al., "<a href='http://scholar.google.com/scholar?q="New+Compounds+Related+to+Podophyllotoxin+and+Congeners%3A+Synthesis%2C+Structure+Elucidation+and+Biological+Testing"'>New Compounds Related to Podophyllotoxin and Congeners: Synthesis, Structure Elucidation and Biological Testing</a>". Acta Chemica Scandinavica, vol. 47 (1993), pp. 1190-1200.</td></tr><tr><td class="patent-data-table-td ">10</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Hansen et al., New Compounds Related to Podophyllotoxin and Congeners: Synthesis, Structure Elucidation and Biological Testing . Acta Chemica Scandinavica, vol. 47 (1993), pp. 1190 1200.</td></tr><tr><td class="patent-data-table-td ">11</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Hartwell and Schrecker, "<a href='http://scholar.google.com/scholar?q="The+Chemistry+of+Podophyllum"'>The Chemistry of Podophyllum</a>", Progress in the Chemistry of Organic Natural Products, pp. 84-166, 1957.</td></tr><tr><td class="patent-data-table-td ">12</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Hartwell and Schrecker, The Chemistry of Podophyllum , Progress in the Chemistry of Organic Natural Products, pp. 84 166, 1957.</td></tr><tr><td class="patent-data-table-td ">13</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Jones et al., "<a href='http://scholar.google.com/scholar?q="Synthesis+of+%28%C2%B1%29-4-Deoxypodophyllotoxin%2C+%28%C2%B1%29-Podophyllotoxin+and+%28%C2%B1%29-Epipodophyllotoxin"'>Synthesis of (±)-4-Deoxypodophyllotoxin, (±)-Podophyllotoxin and (±)-Epipodophyllotoxin</a>", Journal of the Chemical Society, Perkin Transactions 1, Nov., 1993, pp. 2541-2548.</td></tr><tr><td class="patent-data-table-td ">14</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Jones et al., Synthesis of ( ) 4 Deoxypodophyllotoxin, ( ) Podophyllotoxin and ( ) Epipodophyllotoxin , Journal of the Chemical Society, Perkin Transactions 1, Nov., 1993, pp. 2541 2548.</td></tr><tr><td class="patent-data-table-td ">15</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Terada et al., "<a href='http://scholar.google.com/scholar?q="Antitumor+Agents.+I.+DNA+Topoisomerase+II+Inhibitory+Activity+and+the+Structural+Relationship+of+Podophyllotoxin+Derivatives+as+Antitumor+Agents"'>Antitumor Agents. I. DNA Topoisomerase II Inhibitory Activity and the Structural Relationship of Podophyllotoxin Derivatives as Antitumor Agents</a>", Chem. Pharm. Bull., 40(10) 2720-2727, 1992.</td></tr><tr><td class="patent-data-table-td ">16</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Terada et al., "<a href='http://scholar.google.com/scholar?q="Antitumor+Agents.+I.+DNA+Topoisomerase+II+Inhibitory+Activity+and+the+Structure+Relationship+of+Podophyllotoxin+Derivatives+as+Antitumor+Agents"'>Antitumor Agents. I. DNA Topoisomerase II Inhibitory Activity and the Structure Relationship of Podophyllotoxin Derivatives as Antitumor Agents</a>", Chemical &amp; Pharmaceutical Bulletin, vol. 40, No. 10, Oct. 1992, pp. 2720-2727.</td></tr><tr><td class="patent-data-table-td ">17</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Terada et al., Antitumor Agents. I. DNA Topoisomerase II Inhibitory Activity and the Structural Relationship of Podophyllotoxin Derivatives as Antitumor Agents , Chem. Pharm. Bull., 40(10) 2720 2727, 1992.</td></tr><tr><td class="patent-data-table-td ">18</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Terada et al., Antitumor Agents. I. DNA Topoisomerase II Inhibitory Activity and the Structure Relationship of Podophyllotoxin Derivatives as Antitumor Agents , Chemical &amp; Pharmaceutical Bulletin, vol. 40, No. 10, Oct. 1992, pp. 2720 2727.</td></tr><tr><td class="patent-data-table-td ">19</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Thurston et al., "<a href='http://scholar.google.com/scholar?q="Antitumor+Agents.+100.+Inhibition+of+Human+DNA+Topoisomerase+II+by+Cytotoxic+Ether+and+Ester+Derivatives+of+Podophyllotoxin+and+%CE%B1-Peltatin"'>Antitumor Agents. 100. Inhibition of Human DNA Topoisomerase II by Cytotoxic Ether and Ester Derivatives of Podophyllotoxin and α-Peltatin</a>", Journal of Medical Chemistry, vol. 32, No. 3, Mar. 1986, pp. 604-608.</td></tr><tr><td class="patent-data-table-td ">20</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Thurston et al., "<a href='http://scholar.google.com/scholar?q="Antitumor+Agents.+78.+Inhibition+of+Human+DNA+Topoisomerase+II+by+Podophyllotoxin+and+%CE%B1-Peltatin+Analogues"'>Antitumor Agents. 78. Inhibition of Human DNA Topoisomerase II by Podophyllotoxin and α-Peltatin Analogues</a>", J. Med. Chem., 29:1547-1550, 1986.</td></tr><tr><td class="patent-data-table-td ">21</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Thurston et al., Antitumor Agents. 100. Inhibition of Human DNA Topoisomerase II by Cytotoxic Ether and Ester Derivatives of Podophyllotoxin and Peltatin , Journal of Medical Chemistry, vol. 32, No. 3, Mar. 1986, pp. 604 608.</td></tr><tr><td class="patent-data-table-td ">22</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Thurston et al., Antitumor Agents. 78. Inhibition of Human DNA Topoisomerase II by Podophyllotoxin and Peltatin Analogues , J. Med. Chem., 29:1547 1550, 1986.</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S022000">514/22</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S468000">514/468</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc549/defs549.htm&usg=AFQjCNGCnPB8vsKyTEtdLCsunv3UB46HFw#C549S299000">549/299</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C07D0493040000">C07D493/04</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C07D0307920000">C07D307/92</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031423000">A61K31/423</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C07D0491056000">C07D491/056</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031415000">A61K31/415</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C07D0498040000">C07D498/04</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031340000">A61K31/34</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61P0037060000">A61P37/06</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C07D0491040000">C07D491/04</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031420000">A61K31/42</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031343000">A61K31/343</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C07D0209600000">C07D209/60</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C07D0261200000">C07D261/20</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C07D0231540000">C07D231/54</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C07D209/60">C07D209/60</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C07D491/04">C07D491/04</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C07D261/20">C07D261/20</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C07D307/92">C07D307/92</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=fs1FBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C07D493/04">C07D493/04</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">C07D261/20</span>, <span class="nested-value">C07D209/60</span>, <span class="nested-value">C07D307/92</span>, <span class="nested-value">C07D491/04</span>, <span class="nested-value">C07D493/04</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Jun 1, 2010</td><td class="patent-data-table-td ">FP</td><td class="patent-data-table-td ">Expired due to failure to pay maintenance fee</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20100414</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Apr 14, 2010</td><td class="patent-data-table-td ">LAPS</td><td class="patent-data-table-td ">Lapse for failure to pay maintenance fees</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Nov 16, 2009</td><td class="patent-data-table-td ">REMI</td><td class="patent-data-table-td ">Maintenance fee reminder mailed</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Nov 7, 2006</td><td class="patent-data-table-td ">FPB1</td><td class="patent-data-table-td ">Expired due to reexamination which canceled all claims</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Sep 23, 2005</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Oct 1, 2002</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20020816</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Nov 6, 2001</td><td class="patent-data-table-td ">REMI</td><td class="patent-data-table-td ">Maintenance fee reminder mailed</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Nov 1, 2001</td><td class="patent-data-table-td ">SULP</td><td class="patent-data-table-td ">Surcharge for late payment</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Nov 1, 2001</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jan 22, 1996</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">UNIVERSIDAD DE SALAMANCA, SPAIN</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GORDALIZA, MARINA;LOPEZ, MARIA LUISA;CASTRO, MARIA ANGELES;AND OTHERS;REEL/FRAME:007776/0447;SIGNING DATES FROM 19950108 TO 19960108</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U0Uf6mXIOl4LREFo2MB2wJ0vSf0Hg\u0026id=fs1FBAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U2GhZy8E9xpVIXAy7Wl3EaK0ew1RQ\u0026id=fs1FBAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U3j-E7E1M38A8uEFoyLFpvnagbSZg","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Immunosuppressive_cyclolignan_derivative.pdf?id=fs1FBAABERAJ\u0026output=pdf\u0026sig=ACfU3U3kqdNdn063vWepXN8Cl6YL85POYg"},"sample_url":"http://www.google.com/patents/reader?id=fs1FBAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>